Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Cambridge University Cancer Research Centre in the United Kingdom is one of three healthcare entities that will benefit from IBM Corp.'s Shared University Research (SUR) award.
ScImage Inc. is partnering with Stryker Corp. to provide an orthopedic-focused imaging and information management product based on ScImage's Enterprise PACS, PICOMEnterprise.
The VHA Inc. signed two agreements that will offer its network of community-owned healthcare organizations a larger selection of emergency department information systems software.
Kaleida Health in Buffalo, N.Y., will take delivery from Eastman Kodak Co. on 13 Kodak DirectView CR 850 and CR 950 systems and four Kodak DirectView CR Long-Length imaging systems.
Siemens Medical Solutions will supply information technology (IT) infrastructure and support services, as the company collaborates with Anceta LLC on the commercial development of the largest repository of patient information in the United States.
Eclipsys Corp. will add Clinician Support Technology Inc. (CST) technology features to its line of advanced clinical, financial and management information software and services.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.
